SMN1 and proximal spinal muscular atrophy: The next year, the authors reported that the scAAV9 vector carrying the SMN gene (scAAV9-SMN) was injected into the facial vein of neonatal SMA model mice on the first day after birth, resulting in prolonged survival of one of the treated mice [111].